9 Red Days In A Row: PJT Partners Stock Is Down 19%
A nine-day slide has erased significant value from the stock, but its underlying numbers tell a more complicated story.
PJT Partners (PJT) stock has now moved lower for 9 consecutive trading days, a cumulative loss of 19%. That streak has erased about $928 million from the company’s market value, which now stands at about $4.1 billion. As of 9/17/2026, PJT Partners stock trades at about $151.23 a share.
The recent decline is also a sharp reversal. While the stock has returned -2.3% over the last three months, that window includes this nine-day slide; the period before it was one of gains.
How The Streak Stacks Up Against The S&P 500
Here is how PJT stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | PJT | S&P 500 |
|---|---|---|
| 1D | -0.9% | 1.1% |
| 9D (Current Streak) | -18.6% | -1.4% |
| 1M (21D) | -10.8% | -0.7% |
| 3M (63D) | -2.3% | 2.9% |
| YTD 2026 | -9.1% | 11.6% |
| 2025 | 6.6% | 16.4% |
| 2024 | 56.2% | 23.3% |
| 2023 | 40.0% | 24.2% |
The stock’s fundamentals present a mixed picture.
This move is specific to the company, not the broader market. Over the same 9 trading days, the S&P 500 returned -1.4%. The sources do not show why the move happened. On one hand, revenue over the last twelve months grew 22.9%, which is above the 10.2% median for S&P 500 Financials stocks.
On the other hand, its operating margin of 22.0% sits below the 26.9% median for its peers. The stock also trades at a price-to-earnings multiple of 20.3, compared to a median of 14.0 among S&P 500 Financials stocks.
A streak is a signal to check the business against the price.
A sustained move in either direction is information about momentum and investor attention. It is not an instruction to act. The disciplined response is to treat the new price as an opportunity to re-evaluate the business you own or are watching.
The data provides a starting point for that assessment. It allows an investor to weigh the company’s growth against its current profitability and valuation relative to its peers.
If the drop has you weighing an entry, resist buying on price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still hold up.
Those watching the group rather than this one name have another route: our ETF Scorecard shows how the U.S. broker-dealers & securities exchanges funds stack up. Any one of those funds is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.
Weakness In One Name Should Be Noise, Not News
For a diversified holder, a streak like this is a data point. For a concentrated one, it is a hole in the plan. The difference is never the stock; it is the portfolio built around it.
Building that portfolio is what the Trefis High Quality (HQ) Portfolio does: roughly 30 businesses with the cash generation and balance-sheet strength to absorb a bad month, selected and rebalanced by rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Make the next streak, in either direction, someone else’s drama.